You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ICI (ICB)

Showing 1 - 25 of 180
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Immune System Disorder, Inflammatory Reaction Trial in Montreal

Recruiting
  • Cancer
  • +3 more
    • Montreal, Quebec, Canada
      Jewish General Hospital
    Nov 30, 2021

    Oligoprogressive Trial (IMSA101, Immune checkpoint inhibitor, PULSAR)

    Not yet recruiting
    • Oligoprogressive
    • (no location specified)
    May 5, 2023

    Primary and Metastatic Tumors in Renal Cell Carcinoma and

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Immune checkpoint inhibitor targeting PD1
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center - Philadelphia
    Jan 27, 2023

    Oligometastatic Disease Trial (IMSA101, Immune checkpoint inhibitor, PULSAR)

    Not yet recruiting
    • Oligometastatic Disease
    • (no location specified)
    May 5, 2023

    Intestinal Biomarker Analysis After ECP for ICI Colitis

    Recruiting
    • Colitis
    • Immune Checkpoint Inhibitor-Related Colitis
    • Intestinal tissue analysis
    • Freiburg, Baden Württemberg, Germany
      Freiburg University Medical Center
    Oct 5, 2023

    Blocking TNF to Potentiate ICI-dependent Immune Awakening in

    Recruiting
    • Melanoma
    • +2 more
      • Toulouse, France
        Institut Claudius Regaud
      May 25, 2023

      Biliary Tract Cancer, Immune Checkpoint Inhibitor, Predictive Cancer Model Trial in Beijing (Immune Checkpoint Inhibitors)

      Recruiting
      • Biliary Tract Cancer
      • +2 more
      • Immune Checkpoint Inhibitors
      • Beijing, Beijing, China
        Chinese Academy of Medical Sciences & Peking Union Medical Colle
      Oct 5, 2023

      Colorectal Cancer Trial in Koege (Influenza vaccine, Pembrolizumab)

      Not yet recruiting
      • Colorectal Cancer
      • Koege, Zealand, Denmark
        Center for Surgical Science, Department of Surgery, Zealand Univ
      Jun 9, 2023

      Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine

      Completed
      • Immune Checkpoint Inhibitor
      • Endocrine Toxicity
        • Nanjing, Jiangsu, China
          First Affiliated Hospital, Nanjing Medical University
        Jan 6, 2023

        Atezolizumab Plus Bevacizumab in Advanced HCC

        Recruiting
        • Advanced Hepatocellular Carcinoma
        • Atezolizumab plus bevacizumab
        • Seongnam-si, Gyeonggi-do, Korea, Republic of
          Cha Medical Center
        Oct 30, 2022

        Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

        Active, not recruiting
        • Non Small Cell Lung Cancer
        • Immune signature in serum associated to the metabolic signature
        • Meta-genomic signature of intestinal flora
        • La Tronche, Isère, France
          University Hospital, Grenoble
        Jan 6, 2023

        Advanced Solid Tumors, Lymphoma, Gastric Cancer Trial in United States (FT500, Nivolumab, Pembrolizumab)

        Completed
        • Advanced Solid Tumors
        • +17 more
        • San Diego, California
        • +3 more
        Jan 27, 2023

        Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC

        Recruiting
        • Non-Small Cell Lung Cancer
        • Neoadjuvant immunochemotherapy
        • Neoadjuvant chemotherapy
        • Beijing, Beijing, China
          National Cancer Center/Cancer Hospital,Chinese Academy of Medica
        Aug 1, 2023

        Pain, Postoperative, Shoulder Pain, Surgical Procedure, Unspecified Trial in Santiago (Interscalene Block, Infraclavicular -

        Not yet recruiting
        • Pain, Postoperative
        • +3 more
        • Interscalene Block
        • Infraclavicular - Anterior Supraescapular Nerve Blocks
        • Santiago, Metropolitana, Chile
          Hospital Clínico Universidad de Chile
        Nov 14, 2022

        Melanoma Stage IV, Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in Oslo (Fecal Microbiota

        Recruiting
        • Melanoma Stage IV
        • +4 more
        • Fecal Microbiota Transplant (FMT)
        • Oslo, Norway
          Oslo University Hospital
        Aug 29, 2022

        Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States

        Recruiting
        • Advanced or Metastatic Solid Tumors
        • +11 more
        • Tucson, Arizona
        • +11 more
        Dec 2, 2022

        Schizophrenia Trial in Shanghai (Transcranial Magenetic Stimulation, Sham Transcranial Magenetic Stimulation)

        Recruiting
        • Schizophrenia
        • Transcranial Magenetic Stimulation
        • Sham Transcranial Magenetic Stimulation
        • Shanghai, Shanghai, China
          Shanghai Pudong New Area Mental Health Center
        Sep 13, 2022

        Postoperative Pain Trial in Madinat al Fayyum (ICSSB group, ISB group)

        Completed
        • Postoperative Pain
        • ICSSB group
        • ISB group
        • Madīnat al Fayyūm, Faiyum Governorate, Egypt
          Fayoum University hospital
        Mar 15, 2022

        Invasive Candidiasis Trial in France (Biomarker strategy, Routine strategy)

        Recruiting
        • Invasive Candidiasis
        • Biomarker strategy
        • Routine strategy
        • Arras, France
        • +9 more
        Aug 18, 2022

        NSCLC Trial in Guangzhou (ICI, Chemotherapy, Placebo)

        Recruiting
        • Non-small Cell Lung Cancer
        • Guangzhou, Guangdong, China
          Guangdong Provincial Hospital of Traditional Chinese Medicine
        Aug 11, 2022

        Breast Cancer, Contrast Enhanced Ultrasound Trial in Hershey (Lumason)

        Not yet recruiting
        • Breast Cancer
        • Contrast Enhanced Ultrasound
        • Hershey, Pennsylvania
          Penn State Health College of Medicine
        Jul 19, 2023

        Solid Tumor, Adult Trial (IMSA101, Immune Checkpoint Inhibitor)

        Not yet recruiting
        • Solid Tumor, Adult
        • (no location specified)
        Sep 6, 2023

        Cancer, Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors Trial in Zurich (Fecal Microbiota Transplantation (FMT))

        Recruiting
        • Cancer
        • +2 more
        • Fecal Microbiota Transplantation (FMT)
        • Zurich, Switzerland
          University of Zurich, University Hospital Zurich
        Jun 14, 2022

        Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (Fecal microbiota transplantation)

        Recruiting
        • Melanoma Stage III
        • Melanoma Stage IV
        • Fecal microbiota transplantation
        • Amsterdam, Netherlands
          Antoni van Leeuwenhoek
        Jul 8, 2022

        Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in

        Not yet recruiting
        • Metastatic Triple-Negative Breast Carcinoma
        • 89Zr-atezolizumab PET/CT
        • (no location specified)
        Feb 22, 2023